Cargando…
Production and Immunogenicity of a Tag-Free Recombinant Chimera Based on PfMSP-1 and PfMSP-3 Using Alhydrogel and Dipeptide-Based Hydrogels
A fusion chimeric vaccine comprising multiple protective domains of different blood-stage Plasmodium falciparum antigens is perhaps necessary for widening the protective immune responses and reducing the morbidity caused by the disease. Here we continue to build upon the prior work of developing a r...
Autores principales: | Anand, Gaurav, Biswas, Saikat, Yadav, Nitin, Mukherjee, Paushali, Chauhan, Virander Singh |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8310097/ https://www.ncbi.nlm.nih.gov/pubmed/34358198 http://dx.doi.org/10.3390/vaccines9070782 |
Ejemplares similares
-
Evolution of Genetic Polymorphisms of Plasmodium falciparum Merozoite Surface Protein (PfMSP) in Thailand
por: Kuesap, Jiraporn, et al.
Publicado: (2014) -
The N-Terminal Region of Plasmodium falciparum MSP10 Is a Target of Protective Antibodies in Malaria and Is Important for PfGAMA/PfMSP10 Interaction
por: Nagaoka, Hikaru, et al.
Publicado: (2019) -
Fast track antibody V-gene rescue, recombinant expression in plants and characterization of a PfMSP4-specific antibody
por: Kapelski, Stephanie, et al.
Publicado: (2015) -
The generation and evaluation of recombinant human IgA specific for Plasmodium falciparum merozoite surface protein 1-19 (PfMSP1(19))
por: Shi, Jianguo, et al.
Publicado: (2011) -
Transdermal Immunization of Elastic Liposome-Laden Recombinant Chimeric Fusion Protein of P. falciparum (PfMSP-Fu(24)) Mounts Protective Immune Response
por: Chaudhari, Ramesh, et al.
Publicado: (2021)